120 related articles for article (PubMed ID: 2071896)
1. Invariant chain influences post-translational processing of HLA-DR molecules.
Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
[TBL] [Abstract][Full Text] [Related]
2. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
3. Structure, biosynthesis, and polymorphism of chicken MHC class II (B-L) antigens and associated molecules.
Guillemot F; Turmel P; Charron D; Le Douarin N; Auffray C
J Immunol; 1986 Aug; 137(4):1251-7. PubMed ID: 2942601
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers.
Hmama Z; Gabathuler R; Jefferies WA; de Jong G; Reiner NE
J Immunol; 1998 Nov; 161(9):4882-93. PubMed ID: 9794422
[TBL] [Abstract][Full Text] [Related]
5. The role of the Ia-invariant chain complex in the posttranslational processing and transport of Ia and invariant chain glycoproteins.
Simonis S; Miller J; Cullen SE
J Immunol; 1989 Dec; 143(11):3619-25. PubMed ID: 2584710
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
Machamer CE; Cresswell P
J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
[TBL] [Abstract][Full Text] [Related]
7. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
Vigna JL; Smith KD; Lutz CT
J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
Nguyen QV; Reyes VE; Humphreys RE
Arch Biochem Biophys; 1995 Feb; 317(1):128-32. PubMed ID: 7872774
[TBL] [Abstract][Full Text] [Related]
9. Assembly of major histocompatibility complex class II subunits with invariant chain.
Neumann J; Koch N
FEBS Lett; 2005 Nov; 579(27):6055-9. PubMed ID: 16242130
[TBL] [Abstract][Full Text] [Related]
10. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
Khalil H; Brunet A; Thibodeau J
J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
[TBL] [Abstract][Full Text] [Related]
11. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
12. Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.
Holt GD; Swiedler SJ; Freed JH; Hart GW
J Immunol; 1985 Jul; 135(1):399-407. PubMed ID: 3873494
[TBL] [Abstract][Full Text] [Related]
13. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
Henne C; Schwenk F; Koch N; Möller P
Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
15. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA; Cresswell P
J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
[TBL] [Abstract][Full Text] [Related]
16. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of the oligosaccharides of DR1 and DQw1 molecules.
Iturbe S; Narasimhan S; Letarte M
J Immunol; 1986 Jun; 136(12):4596-603. PubMed ID: 3486906
[TBL] [Abstract][Full Text] [Related]
19. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
Spiro RC; Sairenji T; Humphreys RE
J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]